Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Ng

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
The Medical Clinics of North America|July 1, 1987
Quality performance in the physician's officeR H Ng
Clinics in Laboratory Medicine|June 1, 1986
Selecting instrumentation for physician's office testingR H Ng
Clinical Chemistry|October 1, 1987
HDL-cholesterol assay with the Abbott "Vision System" evaluatedR H Ng, M Altaffer
Biochemistry|November 14, 1978
Deenergization of nerve terminals by beta-bungarotoxinR H Ng, B D Howard
Clinical Chemistry|March 1, 1983
Lack of ferritin concentration at the decision level among commercial quality-control materialsR H Ng, B E Statland
Journal of Neurochemistry|January 1, 1981
Inhibition by neurotoxic phospholipases A2 of synaptosomal uptake of gamma-aminobutyric acidR H Ng, B D Howard
Clinical Chemistry|October 1, 1984
Better quality control of serum CK-MB determinationsR H Ng, B E Statland
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1976
Subcellular distribution and some properties of homocarnosine-carnosine synthetase from chick red blood cellsR H Ng, F D Marshall
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1976
Distribution of homocarnosine-carnosine synthetase in tissues of rat, mouse, chick and frogR H Ng, F D Marshall
Brain Research|January 28, 1977
Failure of a phospholipase A inhibitor to inhibit beta-bungarotoxin phospholipase AR H Ng, B D Howard
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
The Medical Clinics of North America|July 1, 1987
Quality performance in the physician's officeR H Ng
Clinics in Laboratory Medicine|June 1, 1986
Selecting instrumentation for physician's office testingR H Ng
Clinical Chemistry|October 1, 1987
HDL-cholesterol assay with the Abbott "Vision System" evaluatedR H Ng, M Altaffer
Biochemistry|November 14, 1978
Deenergization of nerve terminals by beta-bungarotoxinR H Ng, B D Howard
Clinical Chemistry|March 1, 1983
Lack of ferritin concentration at the decision level among commercial quality-control materialsR H Ng, B E Statland
Journal of Neurochemistry|January 1, 1981
Inhibition by neurotoxic phospholipases A2 of synaptosomal uptake of gamma-aminobutyric acidR H Ng, B D Howard
Clinical Chemistry|October 1, 1984
Better quality control of serum CK-MB determinationsR H Ng, B E Statland
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1976
Subcellular distribution and some properties of homocarnosine-carnosine synthetase from chick red blood cellsR H Ng, F D Marshall
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1976
Distribution of homocarnosine-carnosine synthetase in tissues of rat, mouse, chick and frogR H Ng, F D Marshall
Brain Research|January 28, 1977
Failure of a phospholipase A inhibitor to inhibit beta-bungarotoxin phospholipase AR H Ng, B D Howard
Pageof 5